A Phase 2, Randomized, Placebo-Controlled, Double-Masked Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRX, an Antisense Inhibitor of Complement Factor B, in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)

  • Casazza, Marina (Researcher)
  • Donner, Nadine (Researcher)
  • Eidherr, Markus (Researcher)
  • Gärtner, Michaela (Researcher)
  • Khalil, Haidar (Researcher)
  • Laubichler, Peter (Researcher)
  • Mariacher, Siegfried (Researcher)
  • Murauer, Olivia (Researcher)
  • Pomberger, Leon Julian (Researcher)
  • Schneider, Sophie (Researcher)
  • Silber, Christina (Researcher)
  • Strauß, Rupert (Researcher)
  • Strohmaier, Clemens (Researcher)
  • Waser, Klemens (Researcher)
  • Wesely, Ingrid (Researcher)
  • Bolz, Matthias (PI)

Project: Clinical studies › Clinical Study (Industry project)

Project Details

Description

A Phase 2, Randomized, Placebo-Controlled, Double-Masked Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRX, an Antisense Inhibitor of Complement Factor B, in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)
StatusFinished
Effective start/end date02.03.2022 → 01.02.2024

Fields of science

  • 302007 Ophthalmology